About Strateos
Strateos is a Healthcare company based in Menlo Park (United States) founded in 2019. Provider of cloud based platform provides data driven information for biotech research. Strateos has raised $72.6 million across 3 funding rounds from investors including Lilly, HHS and DCVC. The company has 147 employees. Its chief executive, as recorded, is David Lynch. Strateos offers products and services including Cloud Lab, AI for Drug Discovery, Assay Onboarding and Development, and High Content Imaging. Its focus areas include HealthTech, Life Sciences Tech, Diversified and Life Sciences. Its legal entity is Strateos, Inc. Its competitors include Veeva Systems, Instem and SignalPath; 2 of its 3 listed competitors have raised funding.
Company details
Provider of the cloud-based platform provides data-driven information for biotech research. It offers a cloud-based platform that provides data-driven information for biotech research. The platform helps in drug discovery and synthetic biology research. Its solutions include robotic cloud lab, scale on-site, and on-demand discovery biology among others.
- Headquarters Menlo Park, United States
- Employees 147
- SectorsHealthcare
- Phone•••• ••••
- Website strateos.com
- Social LinkedIn X Facebook YouTube
- Legal Name Strateos, Inc
- Total Equity Funding$72.6M (USD)
in 3 rounds
- Latest Funding Round$56.1M (USD), Series B
Jun 2021
- InvestorsLilly
& 7 more
- Employee Count147
Products & Services of Strateos
Strateos offers a comprehensive portfolio of products and services, including Cloud Lab, AI for Drug Discovery, Assay Onboarding and Development, and High Content Imaging.
Platform for remote control of scientific experiments and workflows.
Tools to accelerate drug discovery through automated data analysis.
Services for developing and optimizing assays in high-throughput settings.
System for advanced imaging in tissue and synthetic biology applications.
Funding Insights of Strateos
Strateos has successfully raised a total of $72.6M across 3 strategic funding rounds. The most recent funding activity was a Series B round of $56.1 million completed in June 2021. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $72.6M
- Total Rounds 3
- Last Round Series B — $56.1M
- First Round $16.5M
(Jul 2019)
- Investors Count 8
All 3 funding rounds of Strateos with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jun 2021 | $56.1M | Series B | – | DCVC, Lux Capital | |
| Sep 2019 | $240,750 | Grant | – | – | |
| Jul 2019 | $16.5M | Series B | – | – | – |
8 investors in total: 8 institutional.
Investors in Strateos
Strateos has secured backing from 8 investors, including venture fund and institutional investors. Prominent investors backing the company include Lilly, HHS and DCVC.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Venture capital firm focused on multiple sectors | dcvc.com | Palo Alto, United States | ||
Seed and early-stage technology companies are funded by Lux Capital. | luxcapital.com | Menlo Park, United States | ||
Private equity and hedge fund investments in healthcare are managed. | ally-bridge.com | Hong Kong, China | ||
Early-stage tech startups are funded by Black Diamond Ventures. | bdventures.com | Los Gatos, United States | ||
Venture capital investing and portfolio management services for accredited investors. | av.vc | |||
Traditional pharmaceutical medicines are developed for multiple health fields. | 1876 | lilly.com | United States | |
Offers private label apparel specifically for girls. | 2006 | mackandco.com | Alameda, United States | |
Public health and human services are overseen by HHS. | 1953 | hhs.gov |
Investor details for Strateos
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Strateos
10 people are tracked at Strateos (6 in leadership, 3 in board & advisors, 1 in team); the tracked headcount is 147.
| Name | Role | Group |
|---|---|---|
David Lynch | Chief Executive Officer | Leadership |
Mark Fischer Colbrie | Leadership | |
not me | Director of Business Development | Leadership |
Mateus Nascimento | Director of Business Development | Leadership |
Wing Cheung | Director Human Resources | Leadership |
Shelly Mathews | Director Of Business Development | Leadership |
Mara Aspinall | Vice Chairman | Board & advisors |
Josh Wolfe | Director | Board & advisors |
Jason Pontin | Chairman | Board & advisors |
Elizabeth Bevels | Project Manager | Team |
Complete people profiles for Strateos
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Strateos
3 dated milestones of Strateos across 2 years, from founding to its latest funding, stage changes and deals.
- Founded Strateos is founded.
- Funding First funding round of $16.5M.
- Funding Latest funding round, Series B, of $56.1M.
Competitors of Strateos
Strateos has 3 listed competitors in our database, 2 of them funded. They include Veeva Systems, Instem and SignalPath.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| veeva.com | 2007 | Pleasanton, United States | $4M | 226 | Cloud-based data management solutions for healthcare are provided. | |
| instem.com | 1969 | Conshohocken, United States | 190 | Software for life science data collection and analysis is provided. | ||
| signalpath.com | 2014 | Durham, United States | $35.64M | Cloud-based software solutions for clinical research sites are provided. |
Detailed competitors of Strateos
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Strateos
Websites that share an audience with Strateos (strateos.com).
Websites whose visitors overlap most with Strateos. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| uncountable.com | 100% | 43.1K | #407,286 | View details |
Top companies in Genomics & Gene Therapy Platforms
3 companies that operate in the same segment as Strateos (Genomics & Gene Therapy Platforms) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
mRNA-based therapeutics for diseases including cancer and infections are developed. | 2010 | Cambridge, Massachusetts, United States | USD 2.78 B | USD 1.94 B | 5,800 | |
Digital sequencing technology for cancer detection is developed. | 2012 | Redwood City, California, United States | USD 557.5 M | USD 982.02 M | 4,867 | |
Circulating tumor DNA is screened for early cancer detection. | 2016 | Menlo Park, California, United States | USD 2 B | USD 147.17 M | 1,141 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Strateos
Complete news archive for Strateos
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Strateos
Strateos was founded in 2019.
Strateos is headquartered in Menlo Park, United States. It is registered at Menlo Park, California, United States.
David Lynch is the CEO of Strateos, as recorded in our data.
Strateos is a funded company, having raised a total of $72.6M across 3 funding rounds to date. The company's 1st funding round was a Series B of $16.5M, raised on Jul 2019.
Strateos has 147 employees.
Provider of the cloud-based platform provides data-driven information for biotech research. It offers a cloud-based platform that provides data-driven information for biotech research. The platform helps in drug discovery and synthetic biology research. Its solutions include robotic cloud lab, scale on-site, and on-demand discovery biology among others.
Strateos's top competitors include Veeva Systems, Instem and SignalPath.
Strateos offers Cloud Lab, AI for Drug Discovery, Assay Onboarding and Development, and High Content Imaging.
Strateos has 8 investors. Key investors include Lilly, HHS, DCVC, Lux Capital, and Ally Bridge Group.
Strateos operates through Strateos, Inc.